Streetbeat News

Stock Prices

ANVS

Annovis Bio announced that its drug Buntanetap has been found to be safe and well tolerated in recent studies, potentially impacting the company's stock positively.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 2:16 pm

DDOG

Datadog's (NYSE:DDOG) short interest has increased by 14.19% since the last report, with 9.75 million shares sold short, representing 3.46% of its float. It would take about 4.75 days to cover all short positions based on current trading volumes. This rise in short interest indicates a more bearish market sentiment towards Datadog, although it has less short interest compared to its peer group average of 4.39%.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 2:15 pm

CFG

Citizens Financial Group (NYSE:CFG) has seen a decrease in short interest, with the short percent of float falling 9.69% to 5.22% of all shares available for trading. The current volume suggests it would take about 4.23 days to cover all short positions. This change in short interest could indicate a shift in market sentiment towards CFG, potentially signaling increased bullishness among investors. CFG's short interest is higher than its peer group average of 3.71%, suggesting more bearish sentiment compared to its peers.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 2:15 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for April 29th, 2024, provides a trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, based on a proprietary formula considering price, volume, and options flow. It offers detailed bullish and bearish price targets for each asset, advising traders to monitor these stocks closely for potential breakouts or reversals. The memo also highlights the importance of staying alert to market changes, with a focus on the Dallas Fed Manufacturing Activity release and the FOMC rate decision as key events that could influence market dynamics.

Portfolio Pulse from RIPS

April 29, 2024 | 2:15 pm

MMAT

Meta Materials (NYSE:MMAT) has seen a 4.42% increase in short interest, now at 11.1% of its float, indicating a bearish market sentiment. With 699 thousand shares sold short and a 2.1-day average to cover, MMAT's short interest is higher than its peer group average of 7.00%. This rise in short interest can be a bullish indicator as it suggests potential for a short squeeze.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 2:15 pm

APEUSD

BTCUSD

DOGEUSD

LDOUSD

MATICUSD

SHIBUSD

Veteran trader 'Cold Blooded Shiller' speculates that certain altcoins, including meme coins, may become irrelevant as the market favors stronger performers and Bitcoin. He notes that some altcoins have failed to maintain their gains, using Polygon (MATIC), Lido (LDO), and ApeCoin (APE) as examples, while others like Dogecoin (DOGE) and Shiba Inu (SHIB) have shown notable gains. The discussion raises questions about the future relevance of underperforming altcoins.

Portfolio Pulse from Khyathi Dalal

April 29, 2024 | 2:10 pm

CNDT

MSFT

Shares of Conduent Inc (NASDAQ:CNDT) rose after announcing a collaboration with Microsoft Corp (NASDAQ:MSFT) to use Microsoft Azure OpenAI Service for generative AI applications in healthcare claims management, customer service platforms, and fraud detection. This partnership aims to enhance quality, productivity, and cycle times for Conduent's global clients, with three pilot projects already underway.

Portfolio Pulse from Shivani Kumaresan

April 29, 2024 | 2:09 pm

ZVSA

ZyVersa Therapeutics shares resumed trading after a circuit breaker halt. This event indicates significant volatility in ZVSA's stock, which could be due to market reactions to company news or broader market movements.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 2:07 pm

AAPL

Apple Inc (NASDAQ:AAPL) is set to host a digital launch event on May 7, focusing on new developments in its iPad and iPhone lineups, with anticipated enhancements and a focus on AI at the WWDC in June. Amid a 12% stock decline in 2024, these launches are viewed as potential catalysts for a rebound, especially with AAPL's stock currently at a critical support level around $165, after fluctuating between $165 and $200 since July 2023.

Portfolio Pulse from Zaheer Anwari

April 29, 2024 | 2:03 pm

MRNA

MYNZ

PFE

mRNA technology, known for its role in COVID-19 vaccines by Pfizer and Moderna, is now promising breakthroughs in cancer diagnostics and treatment. Mainz Biomed reported significant findings from a clinical study on its ColoAlert® CRC screening test, showing high sensitivity and specificity rates. The study, involving 690 subjects across the U.S. and Europe, used novel mRNA biomarkers and a proprietary AI algorithm. Moderna, in partnership with OpenAI, is advancing mRNA medicine further by integrating AI technologies like a customized version of ChatGPT, mChat, into its operations.

Portfolio Pulse from Upwallstreet

April 29, 2024 | 2:02 pm